PMEF
INBX

Point72 Middle East FZE’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Point72 Middle East FZE’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8,927
Closed -$168K – 2193
2023
Q1 		$168K Buy
+8,927
New +$208K 0.01% 988

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Point72 Middle East FZE's INBX Position: Q2 2023 in Review

Point72 Middle East FZE sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2023, closing a stake of 8,927 shares — an estimated $168K sold.

Point72 Middle East FZE first reported a position in INBX in Q1 2023 and held it in 1 quarter. The position peaked at $168K in Q1 2023. 107 funds tracked by Wall St. Rank hold INBX as of Q2 2023.

  • Point72 Middle East FZE reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 8,927 Inhibrx, Inc. Common Stock shares in Q2 2023, an estimated $168K.
  • Point72 Middle East FZE first reported a position in Inhibrx, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's Inhibrx, Inc. Common Stock position peaked at $168K in Q1 2023.
  • 107 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2023.

Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.